A detailed history of Granite Fo LLC transactions in Novartis Ag stock. As of the latest transaction made, Granite Fo LLC holds 14 shares of NVS stock, worth $1,547. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$1,547
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$106.13 - $120.89 $1,485 - $1,692
14 New
14 $1.61 Million
Q1 2024

Sep 05, 2024

BUY
$95.27 - $108.47 $1,333 - $1,518
14 New
14 $1.68 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Granite Fo LLC Portfolio

Follow Granite Fo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Fo LLC with notifications on news.